Figure 1
From: Early diagnostic value of survivin and its alternative splice variants in breast cancer
Survivin quantification in patient sera. (A) Survivin ELISA in control (with no recurrence after initial treatment) and breast cancer patients’ sera. Survivin level was compared with active breast cancer cases (n = 40) to controls (n = 10). Survivin values less than 50 pg/mL were considered normal while a Survivin level of 50-70 pg/mL was considered mild, 70-90 pg/mL moderate and >90 pg/mL as high. (*p < 0.05) (B) Treatment may affect patient sera Survivin levels. In two patients (patient#1), (patient#2) serum Survivin level are measured before and one year after treatment. (Error bar = Mean+/-SD). (BC, breast cancer).